Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
[benign recurrent intrahepatic cholestasis]
Ursodeoxycholic
acid
was
administered
to
a
patient
with
benign
recurrent
intrahepatic
cholestasis
to
prevent
cholestatic
episodes
.
A
detailed
study
of
bile
acid
metabolism
in
this
patient
was
carried
out
in
the
anicteric
and
icteric
phases
before
and
after
ursodeoxycholic
acid
(
750
mg
/
day
)
administration
.
Urinary
,
biliary
and
serum
bile
acids
were
measured
by
gas
chromatography-mass
spectrometry
and
by
high
-performance
liquid
chromatography
techniques
.
During
the
anicteric
phase
the
daily
urinary
excretion
and
serum
concentrations
of
bile
acids
were
within
normal
ranges
,
indicating
normal
hepatic
uptake
and
secretion
of
bile
acids
during
the
cholestasis
-free
period
.
Only
slight
qualitative
differences
from
normal
individuals
were
observed
;
the
relative
proportions
of
deoxycholic
acid
in
the
bile
and
serum
were
higher
,
and
12
-
oxo-lithocholic
acid
was
the
predominant
urinary
bile
acid
.
During
the
icteric
phase
a
marked
increase
in
the
urinary
excretion
of
primary
bile
acids
and
C-
1
,
C-
2
,
C-
4
and
C-
6
hydroxylated
metabolites
was
found
.
Serum
bile
acid
concentrations
increased
before
the
rise
in
bilirubin
,
suggesting
an
acute
disturbance
in
bile
acid
transport
at
the
onset
of
the
cholestatic
attack
.
After
ursodeoxycholic
acid
administration
in
the
anicteric
phase
,
bile
became
enriched
with
the
exogenous
bile
acid
,
but
little
qualitative
change
was
found
in
the
other
metabolites
present
in
the
urine
,
serum
or
bile
during
the
anicteric
or
icteric
phases
.
Prolonged
administration
of
ursodeoxycholic
acid
failed
to
prevent
recurrence
of
a
cholestatic
episode
,
suggesting
that
in
benign
recurrent
intrahepatic
cholestasis
,
oral
ursodeoxycholic
acid
may
be
of
little
benefit
in
the
treatment
or
prevention
of
cholestasis
despite
marked
enrichment
of
the
bile
acid
pool
with
this
hydrophilic
bile
acid
.
Diseases
Validation
Diseases presenting
"relative proportions"
symptom
benign recurrent intrahepatic cholestasis
hodgkin lymphoma, classical
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom